GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Cyclically Adjusted PB Ratio

CV Sciences (CV Sciences) Cyclically Adjusted PB Ratio : 0.30 (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Cyclically Adjusted PB Ratio?

As of today (2024-06-07), CV Sciences's current share price is $0.0949. CV Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.32. CV Sciences's Cyclically Adjusted PB Ratio for today is 0.30.

The historical rank and industry rank for CV Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

CVSI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.13   Max: 2.26
Current: 0.21

During the past years, CV Sciences's highest Cyclically Adjusted PB Ratio was 2.26. The lowest was 0.07. And the median was 0.13.

CVSI's Cyclically Adjusted PB Ratio is ranked better than
92.4% of 737 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs CVSI: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CV Sciences's adjusted book value per share data for the three months ended in Mar. 2024 was $0.014. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.32 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CV Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CV Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Cyclically Adjusted PB Ratio Chart

CV Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.32 0.31 0.08 0.10

CV Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.11 0.13 0.10 0.13

Competitive Comparison of CV Sciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CV Sciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CV Sciences's Cyclically Adjusted PB Ratio falls into.



CV Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CV Sciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0949/0.32
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CV Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CV Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.014/131.7762*131.7762
=0.014

Current CPI (Mar. 2024) = 131.7762.

CV Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.676 100.560 0.886
201409 0.662 100.428 0.869
201412 0.631 99.070 0.839
201503 0.652 99.621 0.862
201506 0.616 100.684 0.806
201509 0.638 100.392 0.837
201512 0.512 99.792 0.676
201603 0.447 100.470 0.586
201606 0.419 101.688 0.543
201609 0.393 101.861 0.508
201612 0.229 101.863 0.296
201703 0.189 102.862 0.242
201706 0.165 103.349 0.210
201709 0.171 104.136 0.216
201712 0.181 104.011 0.229
201803 0.199 105.290 0.249
201806 0.239 106.317 0.296
201809 0.273 106.507 0.338
201812 0.317 105.998 0.394
201903 0.314 107.251 0.386
201906 0.347 108.070 0.423
201909 0.337 108.329 0.410
201912 0.293 108.420 0.356
202003 0.255 108.902 0.309
202006 0.220 108.767 0.267
202009 0.194 109.815 0.233
202012 0.111 109.897 0.133
202103 0.112 111.754 0.132
202106 0.092 114.631 0.106
202109 0.101 115.734 0.115
202112 0.031 117.630 0.035
202203 0.031 121.301 0.034
202206 0.014 125.017 0.015
202209 0.009 125.227 0.009
202212 -0.005 125.222 -0.005
202303 0.033 127.348 0.034
202306 0.025 128.729 0.026
202309 0.023 129.860 0.023
202312 0.018 129.419 0.018
202403 0.014 131.776 0.014

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CV Sciences  (OTCPK:CVSI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CV Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CV Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CV Sciences (CV Sciences) Business Description

Traded in Other Exchanges
Address
9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126
CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.
Executives
William Mccorkle director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr. director 9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md director 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake director 145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay officer: Sr VP Scientific/Regulatory 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling officer: Chief Financial Officer 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser officer: CFO 2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham director C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty director C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin director 1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc. other: Member 10% holding group 6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118